Skip to main content
SpringerLink
Log in

Response to “Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes”

  • Letter to the Editor
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

A Correction to this article was published on 23 March 2023

The Original Article was published on 17 July 2022

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Change history

References

  1. di Folco U, Vallecorsa N, Nardone MR, Pantano AL, Tubili C (2022) Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes. Acta Diabetol 59(10):1287–1294. https://doi.org/10.1007/S00592-022-01936-6

    Article  PubMed  PubMed Central  Google Scholar 

  2. Husain M, Birkenfeld AL, Donsmark M et al (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Eng J Med 381(9):841–851. https://doi.org/10.1056/NEJMOA1901118/SUPPL_FILE/NEJMOA1901118_DATA-SHARING.PDF

    Article  CAS  Google Scholar 

  3. Azoulay L, Suissa S (2017) Sulfonylureas and the risks of cardiovascular events and death: a methodological meta-regression analysis of the observational studies. Diabetes Care 40(5):706–714. https://doi.org/10.2337/DC16-1943

    Article  CAS  PubMed  Google Scholar 

  4. Sato ST, Tosaki T, Kotorii A, et al. (2022) 624-P: effects of semaglutide treatment on dietary behavior in japanese patients with type 2 diabetes mellitus. Diabetes. 71(Supp_1) https://doi.org/10.2337/DB22-624-P

  5. Brindisi MC, Brondel L, Meillon S et al (2019) Proof of concept: Effect of GLP-1 agonist on food hedonic responses and taste sensitivity in poor controlled type 2 diabetic patients. Diabetes Metab Syndr Clin Res Rev 13(4):2489–2494. https://doi.org/10.1016/J.DSX.2019.06.021

    Article  Google Scholar 

Download references

Funding

The authors did not receive support from any organization for the submitted work.

Author information

Authors and Affiliations

  1. Allama Iqbal Medical College, Allama Shabbir Ahmad Usmani Road, Lahore, 54550, Punjab, Pakistan

    Muhammad Rafay Shahzad Cheema

  2. Shaheed Mohtarma Benazir Bhutto Medical College, Liyari, Karachi, Pakistan

    Satesh Kumar

Authors
  1. Muhammad Rafay Shahzad Cheema
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satesh Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Muhammad Rafay Shahzad Cheema.

Ethics declarations

Conflicts of interest

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Managed by Massimo Porta.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised: The country name of corresponding author affiliation was corrected from “India” to “Pakistan”.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheema, M.R.S., Kumar, S. Response to “Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes”. Acta Diabetol 60, 715–716 (2023). https://doi.org/10.1007/s00592-023-02061-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-023-02061-8

Search

Navigation